ASCENTAGE-B News

ASCENTAGE-B: VOLUNTARY ANNOUNCEMENT - ASCENTAGE PHARMA TO PRESENT FOUR STUDIES, INCLUDING AN ORAL REPORT FEATURING THE LATEST DATA OF OLVEREMBATINIB IN SDH-DEFICIENT GIST

Apr 25 06:56

ASCENTAGE-B: 2023 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT

Apr 15 22:27

ASCENTAGE-B: Notification Letter and Request Form to Non-registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications

Apr 15 18:33

ASCENTAGE-B: FORM OF PROXY FOR THE ANNUAL GENERAL MEETING TO BE HELD ON MAY 10, 2024

Apr 15 18:27

ASCENTAGE-B: NOTICE OF ANNUAL GENERAL MEETING

Apr 15 18:23

ASCENTAGE-B: PROPOSED RE-ELECTION OF RETIRING DIRECTORS, PROPOSED GRANTING OF GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES AND NOTICE OF ANNUAL GENERAL MEETING

Apr 15 18:19

ASCENTAGE-B: ANNUAL REPORT 2023

Apr 15 18:12

ASCENTAGE-B: VOLUNTARY ANNOUNCEMENT - ACQUISITION OF SHARES BY THE CHAIRMAN AND EXECUTIVE DIRECTOR

Apr 8 22:52

ASCENTAGE-B: VOLUNTARY ANNOUNCEMENT - ASCENTAGE PHARMA PRESENTS RESULTS FROM THREE STUDIES AT 2024 AMERICAN ASSOCIATION OF CANCER RESEARCH ANNUAL MEETING

Apr 8 07:50

ASCENTAGE-B: VOLUNTARY ANNOUNCEMENT - ACQUISITION OF SHARES BY DIRECTORS

Apr 3 22:45

ASCENTAGE-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024

Apr 3 21:53

ASCENTAGE-B: ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED DECEMBER 31, 2023

Mar 27 21:57

ASCENTAGE-B: NOTICE OF BOARD MEETING

Mar 15 21:27

ASCENTAGE-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024

Mar 6 22:04

ASCENTAGE-B: Voluntary Announcement - Ascentage Pharma to Present Latest Results from Three Preclinical Studies at 2024 American Association of Cancer Research Annual Meeting

Mar 6 07:38

ASCENTAGE-B: Voluntary Announcement - Ascentage Pharma Received Clearance from U.S. FDA to Initiate Global Registrational Phase 3 Clinical Trial for Olverembatinib in Previously Treated Patients with Chronic Phase Chronic Myeloid Leukemia (CML-CP)

Feb 14 07:47

ASCENTAGE-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2024

Feb 6 22:24

ASCENTAGE-B: VOLUNTARY ANNOUNCEMENT - PURCHASE OF SHARES BY THE TRUSTEE FOR THE PURPOSE OF THE 2022 RSU SCHEME

Feb 2 21:39

ASCENTAGE-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2023

Jan 5 22:51

ASCENTAGE-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2023

Dec 5, 2023 22:37